Company Filing History:
Years Active: 2018-2019
Title: Virginia Raymond: Innovator in B-Cell Malignancies
Introduction
Virginia Raymond is a prominent inventor based in Armonk, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting B-cell malignancies. With a total of 2 patents, her work is paving the way for innovative treatments in oncology.
Latest Patents
Virginia's latest patents focus on antibodies that target the membrane-bound IgM (mIgM) of the B-cell receptor complex. These inventions are particularly relevant for B-cell lymphomas and leukemias. The first patent describes the use of these antibodies in treating B-cell malignancies, emphasizing their potential therapeutic applications. The second patent details the production of monoclonal antibodies designated mAb4-2b, mAb1-1, mAb2-2b, and mAb3-2b, which were developed through hybridoma cell lines. Both patents highlight the importance of anti-B-cell mIgM antibodies in advancing treatment options for patients suffering from these conditions.
Career Highlights
Virginia Raymond is currently associated with Welt Bio-Molecular Pharmaceutical, LLC. Her work at this company has been instrumental in the research and development of novel therapeutic strategies for B-cell malignancies.
Collaborations
Virginia collaborates with notable colleagues, including Sydney Welt and David Kostyal, who contribute to her research efforts and the advancement of her innovative projects.
Conclusion
Virginia Raymond's contributions to the field of biotechnology, particularly in the development of targeted therapies for B-cell malignancies, underscore her role as a leading inventor. Her patents represent significant advancements in the treatment of serious health conditions, showcasing her dedication to improving patient outcomes.